AsortinoBeta
Bio-Techne Corp. logo

TECHBio-Techne Corp.

NASDAQStockHealthcareBiotechnology🇺🇸 United StatesISIN US09073M1045bio-techne.com
$72.430.03%
NASDAQ · at close Sep 4, 2026
Tokenized by
Dinari Inc. logoReality logo
2 issuersOn
Arbitrum One logoAvalanche C-Chain logoBase logoEthereum logo
6 chains

Chart data are delayed by 15 minutes.

1D0.03%
1M+0.47%
3M+36.20%
1Y+36.87%
3Y8.04%
5Y43.53%

Main metrics

$11.36B
62.44
$1.16
0.44%
3.1M
1.28
$43.2052-week range$72.62

About TECH

Bio-Techne Corp. is a global life sciences company that develops, manufactures, and sells reagents, analytical instruments, and precision diagnostics for research, diagnostic, and bioprocessing applications. Its portfolio supports workflows across basic research, translational science, and clinical decision-making, serving customers in academic laboratories, biotechnology and pharmaceutical development, and diagnostic settings. The company’s products include proteins, antibodies, immunoassays, ELISA kits, molecular diagnostics, spatial biology tools, and specialized instruments used to detect, measure, and analyze biological activity. Bio-Techne also provides custom services such as antibody development, protein degradation solutions, gene engineering, and cell and gene therapy-related services. Through its Protein Sciences and Diagnostics and Spatial Biology businesses, Bio-Techne plays an important role in enabling scientific discovery, biomarker analysis, and laboratory testing across the global healthcare and life sciences market.

Similar products

Alnylam Pharmaceuticals, Inc. logo
ALNYNASDAQ
$266.11+0.61%
Alnylam Pharmaceuticals, Inc.
Backed Finance logoReality logo
2 issuers · 10 chains
Arrowhead Pharmaceuticals, Inc. logo
ARWRNASDAQ
$86.340.17%
Arrowhead Pharmaceuticals, Inc.
Reality logo
1 issuer · 2 chains
Axsome Therapeutics Inc. logo
AXSMNASDAQ
$206.680.80%
Axsome Therapeutics Inc.
Reality logo
1 issuer · 2 chains
BridgeBio Pharma Inc. logo
BBIONASDAQ
$74.840.76%
BridgeBio Pharma Inc.
Reality logo
1 issuer · 2 chains